Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2010/091/003031
CTRI/2010/091/003031
Completed
Phase 4

Immunogenicity of conjugated typhoid Vi vaccine in children ? Single dose Vs Two doses

DR. Balaji Chinnasami,No.5, Adhilaxmi Flats, Balaji Street, Rajaji Nagar, Villivakkam, Chennai-49Phone- 9445482710e-mail: balajictriumphants@gmail.com0 sites400 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
DR. Balaji Chinnasami,No.5, Adhilaxmi Flats, Balaji Street, Rajaji Nagar, Villivakkam, Chennai-49Phone- 9445482710e-mail: balajictriumphants@gmail.com
Enrollment
400
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
DR. Balaji Chinnasami,No.5, Adhilaxmi Flats, Balaji Street, Rajaji Nagar, Villivakkam, Chennai-49Phone- 9445482710e-mail: balajictriumphants@gmail.com

Eligibility Criteria

Inclusion Criteria

  • •Healthy children between 6mths\-5yrs of age attending immunization clinic, dept. of paediatrics, SRM medical college \& research institute.

Exclusion Criteria

  • •(1\) Children having history of documented typhoid fever (blood culture positive/serum Widal test titre \>1:160\).
  • •(2\) Children who have already received typhoid vaccine.
  • •(3\) Children who have received blood transfusion/immunoglobulins in the last 4 weeks.
  • •(4\) On prolonged steroid therapy (\>4 weeks within last 8 weeks).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
Phase 4
Immune Response to Typhoid vaccination in Infants
CTRI/2019/06/019639Christian Medical College
Active, Not Recruiting
N/A
nderstanding typhoid disease after vaccination: a single centre, randomised, double-blind, placebo-controlled study to evaluate M01ZH09 in a healthy adult challenge model, using Ty21a vaccine as a positive control. - Understanding typhoid disease after vaccination; version 1.
EUCTR2011-000381-35-GBniversity of Oxford99
Completed
N/A
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, IndiaEnteric FeverTyphoid FeverSalmonella Typhi Infection
NCT03554213Stanford University17,292
Completed
Phase 3
Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)Safety IssuesImmunogenicity
NCT04051268PT Bio Farma3,071
Completed
Phase 4
Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in ChildhoodTyphoidParatyphoid Fever
NCT00125047International Vaccine Institute27,231